C. Ann Merrifield, Director at Flexion Therapeutics Inc (FLXN), bought 8,000 shares at $12.64 ($101K) on 2019-05-23, disclosed to the SEC on 2019-05-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| LYRA | BUY | 2021-06-22 | $31K | — | Filing → |
| JNP | BUY | 2016-08-29 | $11K | — | Filing → |
| FLXN | BUY | 2016-06-16 | $13K | — | Filing → |